Thiazide diuretic monotherapy for hypertension: Diuretic's dark side just got darker.

Thiazide diuretic monotherapy for hypertension: Diuretic's dark side just got darker. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Thiazide diuretic monotherapy for hypertension: Diuretic's dark side just got darker. Abstract Text:

B H Rovin,L A Hebert,B H Rovin,L A Hebert,B H Rovin,L A Hebert,

Diuretic monotherapy is the current recommendation of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure for initial antihypertensive therapy. There is mounting concern, however, that the benefits of diuretic's superior blood pressure control may be offset by its multiple metabolic disturbances that increase cardiovascular risk. Reungjui et al. document a new concern, nephrotoxicity by thiazide monotherapy. This and other recently published evidence of diuretic's 'dark side' is discussed.Kidney International (2007) 72, 1423-1426. doi:10.1038/sj.ki.5002656.

Thiazide diuretic monotherapy for hypertension: Diuretic's dark side just got darker. Publishing Authors By Initials

BH Rovin,LA Hebert,BH Rovin,LA Hebert,BH Rovin,LA Hebert,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Thiazide diuretic monotherapy for hypertension: Diuretic's dark side just got darker. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Kidney international

VOLUME: 72

Page Numbers: 1423-6

Journal Abbreviation: Kidney Int.

ISSN: 0085-2538

DAY: 29

MONTH: Dec

YEAR: 2007

Thiazide diuretic monotherapy for hypertension: Diuretic's dark side just got darker. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 323470

Thiazide diuretic monotherapy for hypertension: Diuretic's dark side just got darker. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Thiazide diuretic monotherapy for hypertension: Diuretic's dark side just got darker. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Thiazide diuretic monotherapy for hypertension: Diuretic's dark side just got darker.

AFFILIATION: 1Department of Internal Medicine, Ohio State University Medical Center, Columbus, Ohio, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Kidney Int

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Thiazide diuretic monotherapy for hypertension: Diuretic's dark side just got darker Related Publications

• Amoxicillin pharmacokinetics in pregnant women: modeling and simulations of dosage strategies.
• Analysis of protein folding and oxidation in the endoplasmic reticulum.
• Anti-beta1AR antibodies in dilated cardiomyopathy: are these a new class of receptor agonists?
• Biomarker discovery in human SLE nephritis.
• Comparisons of Models of Cognitive Strategies During a Cycling Maximal Test and Simulated Time Trial: 2265: Board #178 June 1 9:00 AM - 10:30 AM.
• Design and applicability of DNA arrays and DNA barcodes in biodiversity monitoring.
• Differential effects of polyglutamine proteins on nuclear organization and artificial reporter splicing.
• Fluctuation in self-perceived stress and increased risk of flare in patients with lupus nephritis carrying the serotonin receptor 1A -1019 G allele.
• Heterodimers of adenylyl cyclases 2 and 5 show enhanced functional responses in the presence of Galpha(s).
• It's time to take back the health care debate.
• Median filtering in constant time.
• Mutations in the BMP pathway in mice support the existence of two molecular classes of holoprosencephaly.
• N-linked carbohydrates act as lumenal maturation and quality control protein tags.
• Nanocarbon as robust catalyst: mechanistic insight into carbon-mediated catalysis.
• Potential use of DNA barcodes in regulatory science: applications of the Regulatory Fish Encyclopedia.
• SV40 VP2 and VP3 insertion into ER membranes is controlled by the capsid protein VP1: implications for DNA translocation out of the ER.
• Single particle refinement in electron crystallography: A pilot study.
• Spot urine protein/creatinine ratios are unreliable estimates of 24 h proteinuria in most systemic lupus erythematosus nephritis flares.
• Thiazide diuretic monotherapy for hypertension: Diuretic's dark side just got darker.
• Urine concentrating defect in prostaglandin EP1-deficient mice.
• Usual ACE inhibitor therapy in CKD patients is associated with lower plasma aldosterone levels than usual angiotensin receptor blocker therapy.
• What's new in Nicotine & Tobacco Research?
• What's new in Nicotine & Tobacco Research?
• What's new in Nicotine & Tobacco Research?
• What's new in Nicotine & Tobacco Research?
• What's new in Nicotine & Tobacco Research?
• What's new in nicotine & tobacco research?
• [Not Available.]
• [Not Available.]
• [Not Available.]